Anebulo Pharmaceuticals Quote - ANEB

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.54

Bid

1.22

Ask

1.62

Volume

18,618

1.45 Day's Range 1.5877

0.8001 52 Week Range 3.30

Market Cap

39.937M

Previous Close

1.58

Open

1.57

Last Trade

107

1.54

Last Trade Time

Financial Volume

US$ 27,609

VWAP

1.4829

Average Volume (3m)

30,515

Shares Outstanding

25,933,217

Dividend Yield

PE Ratio

-4.58

Earnings Per Share (EPS)

-0.32

Revenue

Net Profit

-8.2M

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.anebulo.com

Headquarters

Dover, Delaware, USA

Founded

Anebulo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ANEB. The last closing price for Anebulo Pharmaceuticals was US$1.58. Over the last year, Anebulo Pharmaceuticals shares have traded in a share price range of US$ 0.8001 to US$ 3.30.

Anebulo Pharmaceuticals currently has 25,933,217 shares outstanding. The market capitalization of Anebulo Pharmaceuticals is US$40.97 million. Anebulo Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.58.

Form 8-K - Current report

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company”...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.15	-8.87573964497	1.69	1.69	1.45	9926	1.64673837	CS
4	-0.23	-12.9943502825	1.77	1.8	1.45	30132	1.63819536	CS
12	-0.3	-16.3043478261	1.84	1.95	0.8001	30515	1.40387932	CS
26	-0.66	-30	2.2	3.08	0.8001	17135	1.58331614	CS
52	-0.91	-37.1428571429	2.45	3.3	0.8001	11718	1.85979529	CS
156	-5.07	-76.7019667171	6.61	7.885	0.8001	10311	2.78713925	CS
260	-5.84	-79.1327913279	7.38	9.33	0.8001	11156	3.90964672	CS

ANEB - Frequently Asked Questions (FAQ)

What is the current Anebulo Pharmaceuticals share price?

The current share price of Anebulo Pharmaceuticals is US$ 1.54

How many Anebulo Pharmaceuticals shares are in issue?

Anebulo Pharmaceuticals has 25,933,217 shares in issue

What is the market cap of Anebulo Pharmaceuticals?

The market capitalisation of Anebulo Pharmaceuticals is USD 40.97M

What is the 1 year trading range for Anebulo Pharmaceuticals share price?

Anebulo Pharmaceuticals has traded in the range of US$ 0.8001 to US$ 3.30 during the past year

What is the PE ratio of Anebulo Pharmaceuticals?

The price to earnings ratio of Anebulo Pharmaceuticals is -4.58

What is the reporting currency for Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals reports financial results in USD

What is the latest annual profit for Anebulo Pharmaceuticals?

The latest annual profit of Anebulo Pharmaceuticals is USD -8.2M

What is the registered address of Anebulo Pharmaceuticals?

The registered address for Anebulo Pharmaceuticals is 838 WALKER ROAD, SUITE 21-2, KENT, DOVER, DELAWARE, 19904

What is the Anebulo Pharmaceuticals website address?

The website address for Anebulo Pharmaceuticals is www.anebulo.com

Which industry sector does Anebulo Pharmaceuticals operate in?

Anebulo Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
EVAXEvaxion Biotech AS	US$ 5.99 (64.56%)	55.41M
ELABPMGC Holdings Inc	US$ 3.0901 (56.07%)	76.48M
PCLAPicoCELA Inc	US$ 4.60 (49.35%)	3.75M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
GODNUGolden Star Acquisition Corporation	US$ 3.11 (-75.82%)	17.51k
GODNGolden Star Acquisition Corporation	US$ 2.93 (-65.67%)	902.76k
NXTTNext Technology Holding Inc	US$ 1.37 (-54.93%)	2.56M
SGLYSingularity Future Technology Ltd	US$ 1.625 (-38.45%)	917.77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90.11 (-38.07%)	8
ACONAclarion Inc	US$ 0.0557 (28.94%)	811.91M
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
RIMEAlgorhythm Holdings Inc	US$ 0.0357 (4.69%)	284.97M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
NVDANVIDIA Corporation	US$ 142.62 (-3.12%)	232.88M